Incyte

INCY Scheduled selling only

CIK 0000879169 #251 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$55.54M

$41.42M on a plan · $14.12M straight out of an exercise

Sold at will

$0.00

0 of 47 sales

Net

−$55.54M

$0.00 against sales at will

By person

27 insiders · 50 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hoppenot Herve

Director

—

$19.77M (1) scheduled

−$19.77M

326,803

0.1612%

$41.03M

−34.2%

CAGNONI PABLO J

President, Global Head of R&D

—

$11.30M (7) scheduled

−$11.30M

183,200

0.0904%

$23.00M

−18.5%

Stein Steven H

CMO & Head of Late-Stage Dev.

—

$7.86M (6) scheduled

−$7.86M

30,916

0.0153%

$3.88M

−67.5%

Mayes Patrick A

EVP & Chief Scientific Officer

—

$6.56M (15) scheduled

−$6.56M

61,441

0.0303%

$7.71M

−8.8%

Morrissey Michael James

EVP, Head of Tech. Operations

—

$5.68M (3) scheduled

−$5.68M

34,065

0.0168%

$4.28M

−52.9%

Clancy Paul J

Director

—

$1.42M (1) scheduled

−$1.42M

25,635

0.0126%

$3.22M

+34.8%

Issa Mohamed Khairie

EVP, Head of U.S. Commercial

—

$1.31M (2) scheduled

−$1.31M

71,797

0.0354%

$9.01M

—

Tray Thomas

Principal Accounting Officer

—

$878.95K (6) scheduled

−$878.95K

21,699

0.0107%

$2.72M

−13.7%

Denton Sheila A.

EVP & General Counsel

—

$465.18K (5) scheduled

−$465.18K

26,569

0.0131%

$3.34M

−19.8%

Heeson Lee

EVP, Head of Incyte Intl

—

$289.02K (1) scheduled

−$289.02K

38,041

0.0188%

$4.78M

—

BAKER BROS. ADVISORS LP entity

Director

—

—

—

28,205,760

13.92%

$3.54B

+0.2%

Meury William

Chief Executive Officer

—

—

—

183,129

0.0903%

$22.99M

—

Stamoulis Christiana

EVP & Chief Financial Officer

—

—

—

125,759

0.0620%

$15.79M

+32.1%

SWAIN PAULA J

EVP, Human Resources

—

—

—

106,482

0.0525%

$13.37M

+23.7%

Iyengar Vijay K

EVP, GMAPPS

—

—

—

40,540

0.0200%

$5.09M

+9.5%

Flannelly Barry P

EVP & General Manager US

—

—

—

35,149

0.0173%

$4.41M

−39.4%

Upadhyay Suketu

EVP & Chief Financial Officer

—

—

—

26,343

0.0130%

$3.31M

—

BIENAIME JEAN JACQUES

Director

—

—

—

24,424

0.0120%

$3.07M

+33.3%

HARRIGAN EDMUND

Director

—

—

—

23,019

0.0114%

$2.89M

+40.8%

FOUSE JACQUALYN A

Director

—

—

—

20,968

0.0103%

$2.63M

+24.8%

Hoffman Richard A.

EVP & General Counsel

—

—

—

16,861

0.0083%

$2.12M

—

Gardner David H

EVP, Chief Strategy Officer

—

—

—

16,824

0.0083%

$2.11M

—

High Katherine A

Director

—

—

—

14,983

0.0074%

$1.88M

+38.4%

Trotta Matteo

EVP, GM, Dermatology US

—

—

—

14,882

0.0073%

$1.87M

+36.8%

BRAWLEY OTIS W

Director

—

—

—

12,894

0.0064%

$1.62M

+47.6%

Basi Ramitpal K

EVP, Human Resources

—

—

—

10,993

0.0054%

$1.38M

—

Schaffert Susanne

Director

—

—

—

7,389

0.0036%

$927.76K

+29.2%

Individual transactions

3

Insider

Date

Role

Action

Shares

Price

Amount

BIENAIME JEAN JACQUES

26 May 2026

Director

Exercised, kept

15,000

$84.53

$1.27M

BAKER BROS. ADVISORS LP

8 May 2026

Director

Exercised, kept indirect

15,000

$84.53

$1.27M

BAKER BROS. ADVISORS LP

8 May 2026

Director

Exercised, kept indirect

15,000

$84.53

$1.27M

Show all 50 transactions →

What was left out

Form 4 filings counted 93

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 6

Sales on a Rule 10b5-1 plan 23

Sales straight out of an exercise 24

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 682,583

History held since 26 Sep 2016